Back to Search Start Over

Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Authors :
Mertens LS
van der Heijden MS
Source :
The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 156-157. Date of Electronic Publication: 2023 Dec 21.
Publication Year :
2024

Abstract

Competing Interests: MSvdH has received research support from Bristol Myers Squibb, AstraZeneca, Roche, and 4SC; and consultancy fees from Bristol Myers Squibb, Merck, Roche, AstraZeneca, Seagen, Pfizer, and Janssen (all paid to the Netherlands Cancer Institute). LSM declares no competing interests.

Subjects

Subjects :
Humans
Cisplatin therapeutic use
Muscles
Chemotherapy, Adjuvant
Cystectomy
Neoplasm Invasiveness
Antineoplastic Combined Chemotherapy Protocols adverse effects
Retrospective Studies
Neoadjuvant Therapy adverse effects
Urinary Bladder Neoplasms drug therapy
Urinary Bladder Neoplasms surgery

Details

Language :
English
ISSN :
1474-5488
Volume :
25
Issue :
2
Database :
MEDLINE
Journal :
The Lancet. Oncology
Publication Type :
Academic Journal
Accession number :
38142700
Full Text :
https://doi.org/10.1016/S1470-2045(23)00626-5
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details